Center-Authored Papers

Filters: Author is Tolar, Jakub  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
Dietz AC, Mehta PA, Vlachos A, Savage SA, Bresters D, Tolar J, Boulad F, Dalle JH, Bonfim C, De La Fuente J et al..  2017.  Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation (HCT) for Inherited Bone Marrow Failure Syndromes (IBMFS): Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium I. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Dietz AC, Savage SA, Vlachos A, Mehta PA, Bresters D, Tolar J, Bonfim C, Dalle JH, De La Fuente J, Skinner R et al..  2017.  Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Inherited Bone Marrow Failure Syndromes (IBMFS): Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Eff. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Du J, Flynn R, Paz K, Ren H-G, Ogata Y, Zhang Q, Gafken PR, Storer BE, Roy NH, Burkhardt JK et al..  2018.  Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.. Blood. 131(15):1743-1754. Abstract
E
Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JCW et al..  2011.  Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.. Blood. 118(9):2618-21. Abstract
G
Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E et al..  2013.  Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(8):1238-43. Abstract
H
Hippen KL, Watkins B, Tkachev V, Lemire AM, Lehnen C, Riddle MJ, Singh K, Panoskaltsis-Mortari A, Vanhove B, Tolar J et al..  2016.  Preclinical Testing of Antihuman CD28 Fab' Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease.. Transplantation. 100(12):2630-2639. Abstract
Hippen KL, Watkins B, Tkachev V, Lemire AM, Lehnen C, Riddle MJ, Singh K, Panoskaltsis-Mortari A, Vanhove B, Tolar J et al..  2016.  Preclinical testing of anti-human CD28 Fab' antibody in a novel nonhuman primate (NHP) small animal rodent model of xenogenic graft-versus-host disease (GVHD).. Transplantation. Abstract
O
Osborn MJ, Webber BR, Knipping F, Lonetree C-L, Tennis N, DeFeo AP, McElroy AN, Starker CG, Lee C, Gabriel R et al..  2015.  Evaluation of TCR Gene Editing achieved by TALENs, CRISPR/Cas9 and megaTAL nucleases.. Molecular therapy : the journal of the American Society of Gene Therapy. Abstract
P
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R et al..  2011.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network,. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):291-9. Abstract
T
Tolar J, Adair JE, Antoniou M, Bartholomae CC, Becker PS, Blazar BR, Bueren J, Carroll T, Cavazzana-Calvo M, Clapp WD et al..  2011.  Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.. Molecular therapy : the journal of the American Society of Gene Therapy. 19(7):1193-8. Abstract
Tolar J, Becker PS, Bueren J, Clapp WD, Hanenberg H, de Heredia CD, Kiem H-P, Navarro S, Qasba P, Río P et al..  2012.  Gene Therapy for Fanconi Anemia: One Step Closer to the Clinic.. Human gene therapy. 23(2):141-144. Abstract
Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID et al..  2012.  Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(7):1007-11. Abstract